Effects of integrating transcranial photobiomodulation with occupational therapy intervention in children with Autism spectrum disorder

Effects of Integrating Transcranial photobiomodulation with Occupational Therapy Intervention on Executive Functions, Sensory Processing and Symptom Profile in Children with Autism Spectrum Disorder - A Randomized Controlled Trial - ASD

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/02/102678

Enrollment

Registered

2026-02-02

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F01-F99- Mental, Behavioral and Neurodevelopmental disorders

Interventions

Intervention1: Transcranial photobiomodulation with occupational therapy intervention: 18 session for each participants 9 weeks protocol weekly twice the session transcranial photobiomodulation for 5

Eligibility

Inclusion criteria

Inclusion criteria: Participants who scored moderate to severe (30- 60) autism severity based on CARS 2 score will be included for the study Participants who have Sensory Processing issues will be included for the study Participants who scored above 60 in Brown Executive Function Attention/Scale Age range of the Participants between 3- 7 years Parents must know either Tamil or English

Exclusion criteria

Exclusion criteria: Participants with comorbid conditions (e.g. Epilepsy and Neurological conditions) Children with Photosensitive or light-triggered medical conditions Presence of metallic or electronic cranial implants Participants with Open wounds or scalp infections Participation in other interventional or neuromodulation studies in the past 3 months Recent head injury or neurosurgery (within 6 months)

Design outcomes

Primary

Measure	Time frame
changes from baseline in executive function composite scores, sensory processing, symptom severity in asdTimepoint: After 9 weeks of intyervention	—

Secondary

Measure	Time frame
EEG spectral analysis changesTimepoint: after 9 weeks of intervention	—

Countries

India

Contacts

Public ContactRaghuram P

Sri Ramachandra Institute of Higher Education and Research

raghurammot@sriramachandra.edu.in9677073853

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026